102 related articles for article (PubMed ID: 20200393)
1. A controlled trial of initial antiviral regimens for HIV-1 infection.
Parienti JJ
N Engl J Med; 2010 Mar; 362(9):854; author reply 855. PubMed ID: 20200393
[No Abstract] [Full Text] [Related]
2. Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine.
Maserati R; De Silvestri A; Uglietti A; Colao G; Di Biagio A; Bruzzone B; Di Pietro M; Re MC; Tinelli C; Zazzi M;
AIDS; 2010 Apr; 24(7):1013-8. PubMed ID: 20124969
[TBL] [Abstract][Full Text] [Related]
3. The art of managing human immunodeficiency virus infection: a balancing act.
Reiss P
Clin Infect Dis; 2009 Nov; 49(10):1602-4. PubMed ID: 19842978
[No Abstract] [Full Text] [Related]
4. Oral preexposure prophylaxis for HIV--another arrow in the quiver?
Michael NL
N Engl J Med; 2010 Dec; 363(27):2663-5. PubMed ID: 21091280
[No Abstract] [Full Text] [Related]
5. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.
Redfield RR; Morrow JS
Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234
[No Abstract] [Full Text] [Related]
6. Efficacy of tenofovir-emtricitabine versus abacavir-lamivudine.
Landman GW; Soonawala D
Clin Infect Dis; 2010 Apr; 50(8):1200; author reply 1200. PubMed ID: 20233045
[No Abstract] [Full Text] [Related]
7. European CHMP issues positive opinion for Atripla.
AIDS Patient Care STDS; 2007 Nov; 21(11):890. PubMed ID: 18338431
[No Abstract] [Full Text] [Related]
8. FDA notifications. Updated Atripla label approved.
AIDS Alert; 2010 Mar; 25(3):36. PubMed ID: 20629262
[No Abstract] [Full Text] [Related]
9. [One year with Atripla. Changeover to complete HIV therapy in a single tablet has proven successful].
Warpakowski A
MMW Fortschr Med; 2009 Apr; 151(18):54-5. PubMed ID: 19769077
[No Abstract] [Full Text] [Related]
10. Tenofovir DF and emtricitabine vs. zidovudine and lamivudine.
Jenny-Avital ER
N Engl J Med; 2006 Jun; 354(23):2506-8; author reply 2506-8. PubMed ID: 16764056
[No Abstract] [Full Text] [Related]
11. Comment on: High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
Parienti JJ
J Antimicrob Chemother; 2009 May; 63(5):1080; author reply 1080-1. PubMed ID: 19158108
[No Abstract] [Full Text] [Related]
12. A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate.
De Clercq E
Expert Opin Pharmacother; 2009 Dec; 10(17):2935-7. PubMed ID: 19929712
[TBL] [Abstract][Full Text] [Related]
13. Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen.
Tamalet C; Tomei C; Henry M; Solas C; Villacian J; Colson P
AIDS; 2007 Nov; 21(18):2551-2. PubMed ID: 18025898
[No Abstract] [Full Text] [Related]
14. Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial.
Martin A; Bloch M; Amin J; Baker D; Cooper DA; Emery S; Carr A
Clin Infect Dis; 2009 Nov; 49(10):1591-601. PubMed ID: 19842973
[TBL] [Abstract][Full Text] [Related]
15. [Simply convincing. New fixed combination for HIV therapy].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():20-3. PubMed ID: 16385865
[No Abstract] [Full Text] [Related]
16. Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patients.
Bickel M; Bodtländer A; Knecht GK; Stephan C; von Hentig N; Kurowski M; Gute P; Klauke S; Lutz T
J Antimicrob Chemother; 2009 Dec; 64(6):1260-4. PubMed ID: 19776037
[TBL] [Abstract][Full Text] [Related]
17. High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
Rey D; Hoen B; Chavanet P; Schmitt MP; Hoizey G; Meyer P; Peytavin G; Spire B; Allavena C; Diemer M; May T; Schmit JL; Duong M; Calvez V; Lang JM
J Antimicrob Chemother; 2009 Feb; 63(2):380-8. PubMed ID: 19036752
[TBL] [Abstract][Full Text] [Related]
18. Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC.
Feinberg J
AIDS Clin Care; 2005 Jan; 17(1):7. PubMed ID: 15717373
[No Abstract] [Full Text] [Related]
19. Generic Truvada approved.
AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
[No Abstract] [Full Text] [Related]
20. Early end for FEM-PrEP HIV prevention trial.
AIDS Patient Care STDS; 2011 Jun; 25(6):383. PubMed ID: 21612547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
